LPP_HUMAN - dbPTM
LPP_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LPP_HUMAN
UniProt AC Q93052
Protein Name Lipoma-preferred partner
Gene Name LPP
Organism Homo sapiens (Human).
Sequence Length 612
Subcellular Localization Nucleus. Cytoplasm. Cell junction. Cell membrane. Found in the nucleus, in the cytoplasm and at cell adhesion sites. Shuttles between the cytoplasm and the nucleus. It has been found in sites of cell adhesion such as cell-to-cell contact and focal ad
Protein Description May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus..
Protein Sequence MSHPSWLPPKSTGEPLGHVPARMETTHSFGNPSISVSTQQPPKKFAPVVAPKPKYNPYKQPGGEGDFLPPPPPPLDDSSALPSISGNFPPPPPLDEEAFKVQGNPGGKTLEERRSSLDAEIDSLTSILADLECSSPYKPRPPQSSTGSTASPPVSTPVTGHKRMVIPNQPPLTATKKSTLKPQPAPQAGPIPVAPIGTLKPQPQPVPASYTTASTSSRPTFNVQVKSAQPSPHYMAAPSSGQIYGSGPQGYNTQPVPVSGQCPPPSTRGGMDYAYIPPPGLQPEPGYGYAPNQGRYYEGYYAAGPGYGGRNDSDPTYGQQGHPNTWKREPGYTPPGAGNQNPPGMYPVTGPKKTYITDPVSAPCAPPLQPKGGHSGQLGPSSVAPSFRPEDELEHLTKKMLYDMENPPADEYFGRCARCGENVVGEGTGCTAMDQVFHVDCFTCIICNNKLRGQPFYAVEKKAYCEPCYINTLEQCNVCSKPIMERILRATGKAYHPHCFTCVMCHRSLDGIPFTVDAGGLIHCIEDFHKKFAPRCSVCKEPIMPAPGQEETVRIVALDRDFHVHCYRCEDCGGLLSEGDNQGCYPLDGHILCKTCNSARIRVLTAKASTDL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MSHPSWLPPKST
---CCCCCCCCCCCC
35.5027251275
11PhosphorylationPSWLPPKSTGEPLGH
CCCCCCCCCCCCCCC
47.6325159151
11O-linked_GlycosylationPSWLPPKSTGEPLGH
CCCCCCCCCCCCCCC
47.6330059200
12PhosphorylationSWLPPKSTGEPLGHV
CCCCCCCCCCCCCCC
52.2525159151
12O-linked_GlycosylationSWLPPKSTGEPLGHV
CCCCCCCCCCCCCCC
52.2530059200
25PhosphorylationHVPARMETTHSFGNP
CCCCEEEEECCCCCC
22.0728555341
25O-linked_GlycosylationHVPARMETTHSFGNP
CCCCEEEEECCCCCC
22.0730059200
26O-linked_GlycosylationVPARMETTHSFGNPS
CCCEEEEECCCCCCC
11.3830059200
26PhosphorylationVPARMETTHSFGNPS
CCCEEEEECCCCCCC
11.3828857561
28PhosphorylationARMETTHSFGNPSIS
CEEEEECCCCCCCEE
32.5328857561
28O-linked_GlycosylationARMETTHSFGNPSIS
CEEEEECCCCCCCEE
32.5330059200
33PhosphorylationTHSFGNPSISVSTQQ
ECCCCCCCEEEECCC
31.3428857561
33O-linked_GlycosylationTHSFGNPSISVSTQQ
ECCCCCCCEEEECCC
31.3430059200
35PhosphorylationSFGNPSISVSTQQPP
CCCCCCEEEECCCCC
17.8528857561
35O-linked_GlycosylationSFGNPSISVSTQQPP
CCCCCCEEEECCCCC
17.8530059200
43AcetylationVSTQQPPKKFAPVVA
EECCCCCCCCCCCCC
68.1826051181
44UbiquitinationSTQQPPKKFAPVVAP
ECCCCCCCCCCCCCC
53.16-
44AcetylationSTQQPPKKFAPVVAP
ECCCCCCCCCCCCCC
53.1625953088
52MalonylationFAPVVAPKPKYNPYK
CCCCCCCCCCCCCCC
44.3926320211
83PhosphorylationDDSSALPSISGNFPP
CCCCCCCCCCCCCCC
30.1827251275
85PhosphorylationSSALPSISGNFPPPP
CCCCCCCCCCCCCCC
31.8327251275
108AcetylationVQGNPGGKTLEERRS
HCCCCCCCCHHHHHH
56.7127452117
108UbiquitinationVQGNPGGKTLEERRS
HCCCCCCCCHHHHHH
56.71-
109PhosphorylationQGNPGGKTLEERRSS
CCCCCCCCHHHHHHH
42.5525159151
115PhosphorylationKTLEERRSSLDAEID
CCHHHHHHHHHHHHH
41.2825159151
116PhosphorylationTLEERRSSLDAEIDS
CHHHHHHHHHHHHHH
28.5825159151
123PhosphorylationSLDAEIDSLTSILAD
HHHHHHHHHHHHHHH
38.9328192239
125PhosphorylationDAEIDSLTSILADLE
HHHHHHHHHHHHHHC
20.0620068231
126PhosphorylationAEIDSLTSILADLEC
HHHHHHHHHHHHHCC
22.3920068231
134PhosphorylationILADLECSSPYKPRP
HHHHHCCCCCCCCCC
25.6023090842
135PhosphorylationLADLECSSPYKPRPP
HHHHCCCCCCCCCCC
43.8618669648
137PhosphorylationDLECSSPYKPRPPQS
HHCCCCCCCCCCCCC
35.2623090842
144PhosphorylationYKPRPPQSSTGSTAS
CCCCCCCCCCCCCCC
35.3226657352
145PhosphorylationKPRPPQSSTGSTASP
CCCCCCCCCCCCCCC
31.3827251275
146PhosphorylationPRPPQSSTGSTASPP
CCCCCCCCCCCCCCC
40.1626657352
148PhosphorylationPPQSSTGSTASPPVS
CCCCCCCCCCCCCCC
22.3826657352
149PhosphorylationPQSSTGSTASPPVST
CCCCCCCCCCCCCCC
32.2825159151
151PhosphorylationSSTGSTASPPVSTPV
CCCCCCCCCCCCCCC
29.8025849741
155PhosphorylationSTASPPVSTPVTGHK
CCCCCCCCCCCCCCC
32.5425627689
156PhosphorylationTASPPVSTPVTGHKR
CCCCCCCCCCCCCCC
23.2425849741
162AcetylationSTPVTGHKRMVIPNQ
CCCCCCCCCEECCCC
43.4630590131
173PhosphorylationIPNQPPLTATKKSTL
CCCCCCCCCCCCCCC
37.7528555341
175PhosphorylationNQPPLTATKKSTLKP
CCCCCCCCCCCCCCC
33.5025159151
175O-linked_GlycosylationNQPPLTATKKSTLKP
CCCCCCCCCCCCCCC
33.5030059200
176AcetylationQPPLTATKKSTLKPQ
CCCCCCCCCCCCCCC
42.1126051181
181AcetylationATKKSTLKPQPAPQA
CCCCCCCCCCCCCCC
41.5226051181
198O-linked_GlycosylationIPVAPIGTLKPQPQP
CCEECCCCCCCCCCC
32.1230059200
200AcetylationVAPIGTLKPQPQPVP
EECCCCCCCCCCCCC
41.2526051181
209O-linked_GlycosylationQPQPVPASYTTASTS
CCCCCCCCEECCCCC
19.5530059200
211O-linked_GlycosylationQPVPASYTTASTSSR
CCCCCCEECCCCCCC
17.2530059200
212O-linked_GlycosylationPVPASYTTASTSSRP
CCCCCEECCCCCCCC
15.4630059200
227PhosphorylationTFNVQVKSAQPSPHY
EEEEEEECCCCCCCE
33.0221945579
231PhosphorylationQVKSAQPSPHYMAAP
EEECCCCCCCEEECC
16.5421945579
234PhosphorylationSAQPSPHYMAAPSSG
CCCCCCCEEECCCCC
7.5721945579
239PhosphorylationPHYMAAPSSGQIYGS
CCEEECCCCCCCCCC
42.2321945579
240PhosphorylationHYMAAPSSGQIYGSG
CEEECCCCCCCCCCC
33.3921945579
244PhosphorylationAPSSGQIYGSGPQGY
CCCCCCCCCCCCCCC
9.4321945579
246PhosphorylationSSGQIYGSGPQGYNT
CCCCCCCCCCCCCCC
30.2621945579
251PhosphorylationYGSGPQGYNTQPVPV
CCCCCCCCCCCCCCC
15.1321945579
253PhosphorylationSGPQGYNTQPVPVSG
CCCCCCCCCCCCCCC
26.2621945579
259PhosphorylationNTQPVPVSGQCPPPS
CCCCCCCCCCCCCCC
19.6521945579
266PhosphorylationSGQCPPPSTRGGMDY
CCCCCCCCCCCCCCE
36.1921945579
267PhosphorylationGQCPPPSTRGGMDYA
CCCCCCCCCCCCCEE
38.8221945579
271SulfoxidationPPSTRGGMDYAYIPP
CCCCCCCCCEEECCC
3.8730846556
273PhosphorylationSTRGGMDYAYIPPPG
CCCCCCCEEECCCCC
7.7521945579
275PhosphorylationRGGMDYAYIPPPGLQ
CCCCCEEECCCCCCC
14.0221945579
287PhosphorylationGLQPEPGYGYAPNQG
CCCCCCCCCCCCCCC
20.0621945579
289PhosphorylationQPEPGYGYAPNQGRY
CCCCCCCCCCCCCCC
15.4821945579
296PhosphorylationYAPNQGRYYEGYYAA
CCCCCCCCEEEEEEC
16.8221945579
297PhosphorylationAPNQGRYYEGYYAAG
CCCCCCCEEEEEECC
11.0821945579
300PhosphorylationQGRYYEGYYAAGPGY
CCCCEEEEEECCCCC
4.3121945579
301PhosphorylationGRYYEGYYAAGPGYG
CCCEEEEEECCCCCC
10.7921945579
307PhosphorylationYYAAGPGYGGRNDSD
EEECCCCCCCCCCCC
21.3821945579
313PhosphorylationGYGGRNDSDPTYGQQ
CCCCCCCCCCCCCCC
49.3821945579
316PhosphorylationGRNDSDPTYGQQGHP
CCCCCCCCCCCCCCC
45.3221945579
317PhosphorylationRNDSDPTYGQQGHPN
CCCCCCCCCCCCCCC
20.5121945579
325PhosphorylationGQQGHPNTWKREPGY
CCCCCCCCCCCCCCC
36.4921945579
327AcetylationQGHPNTWKREPGYTP
CCCCCCCCCCCCCCC
44.8625953088
327SumoylationQGHPNTWKREPGYTP
CCCCCCCCCCCCCCC
44.8625114211
327UbiquitinationQGHPNTWKREPGYTP
CCCCCCCCCCCCCCC
44.86-
332PhosphorylationTWKREPGYTPPGAGN
CCCCCCCCCCCCCCC
27.1321945579
333PhosphorylationWKREPGYTPPGAGNQ
CCCCCCCCCCCCCCC
28.9921945579
345SulfoxidationGNQNPPGMYPVTGPK
CCCCCCCCCCCCCCC
4.1630846556
346PhosphorylationNQNPPGMYPVTGPKK
CCCCCCCCCCCCCCC
10.6421945579
349PhosphorylationPPGMYPVTGPKKTYI
CCCCCCCCCCCCCEE
43.1721945579
352UbiquitinationMYPVTGPKKTYITDP
CCCCCCCCCCEECCC
60.12-
352AcetylationMYPVTGPKKTYITDP
CCCCCCCCCCEECCC
60.1226051181
353MethylationYPVTGPKKTYITDPV
CCCCCCCCCEECCCC
50.09115972579
354PhosphorylationPVTGPKKTYITDPVS
CCCCCCCCEECCCCC
26.7028152594
355PhosphorylationVTGPKKTYITDPVSA
CCCCCCCEECCCCCC
15.6528152594
357PhosphorylationGPKKTYITDPVSAPC
CCCCCEECCCCCCCC
24.6828152594
361PhosphorylationTYITDPVSAPCAPPL
CEECCCCCCCCCCCC
31.7028152594
371UbiquitinationCAPPLQPKGGHSGQL
CCCCCCCCCCCCCCC
65.64-
375PhosphorylationLQPKGGHSGQLGPSS
CCCCCCCCCCCCCCC
31.3525159151
381PhosphorylationHSGQLGPSSVAPSFR
CCCCCCCCCCCCCCC
35.3328555341
382PhosphorylationSGQLGPSSVAPSFRP
CCCCCCCCCCCCCCC
25.9828555341
386PhosphorylationGPSSVAPSFRPEDEL
CCCCCCCCCCCHHHH
24.9327251275
397PhosphorylationEDELEHLTKKMLYDM
HHHHHHHHHHHHHCC
30.4420873877
398UbiquitinationDELEHLTKKMLYDME
HHHHHHHHHHHHCCC
42.41-
400SulfoxidationLEHLTKKMLYDMENP
HHHHHHHHHHCCCCC
4.4630846556
402PhosphorylationHLTKKMLYDMENPPA
HHHHHHHHCCCCCCH
15.1128796482
404SulfoxidationTKKMLYDMENPPADE
HHHHHHCCCCCCHHH
3.2030846556
412PhosphorylationENPPADEYFGRCARC
CCCCHHHHCCCCCCC
16.3322817900
461UbiquitinationQPFYAVEKKAYCEPC
CCEEEEECCEECEEC
35.78-
461MalonylationQPFYAVEKKAYCEPC
CCEEEEECCEECEEC
35.7826320211
469PhosphorylationKAYCEPCYINTLEQC
CEECEECCCCCHHHC
14.12-
504SulfoxidationPHCFTCVMCHRSLDG
CCCEEHHEECCCCCC
1.4130846556
508PhosphorylationTCVMCHRSLDGIPFT
EHHEECCCCCCCCEE
13.7226657352
537PhosphorylationKKFAPRCSVCKEPIM
HHHCCCCCCCCCCCC
31.6526657352
544SulfoxidationSVCKEPIMPAPGQEE
CCCCCCCCCCCCCCC
3.2030846556
567PhosphorylationRDFHVHCYRCEDCGG
CCEEEEEEECCCCCC
11.92-
577PhosphorylationEDCGGLLSEGDNQGC
CCCCCCCCCCCCCCC
44.5727251275
585PhosphorylationEGDNQGCYPLDGHIL
CCCCCCCEECCCEEE
17.4122817900
605PhosphorylationSARIRVLTAKASTDL
CCEEEEEEEECCCCC
24.2122199227
607UbiquitinationRIRVLTAKASTDL--
EEEEEEEECCCCC--
37.32-
609PhosphorylationRVLTAKASTDL----
EEEEEECCCCC----
23.0326846344
610PhosphorylationVLTAKASTDL-----
EEEEECCCCC-----
46.2926846344

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
244YPhosphorylationKinaseSRCP12931
PSP
300YPhosphorylationKinaseSRCP12931
PSP
301YPhosphorylationKinaseSRCP12931
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LPP_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LPP_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EGLN2_HUMANEGLN2physical
22286099
VHL_HUMANVHLphysical
22286099
PNPO_HUMANPNPOphysical
22939629
AGFG1_HUMANAGFG1physical
22863883
HEM2_HUMANALADphysical
22863883
ARPC3_HUMANARPC3physical
22863883
ARPC4_HUMANARPC4physical
22863883
CALR_HUMANCALRphysical
22863883
DBNL_HUMANDBNLphysical
22863883
HPBP1_HUMANHSPBP1physical
22863883
IPO11_HUMANIPO11physical
22863883
P3H1_HUMANP3H1physical
22863883
NIF3L_HUMANNIF3L1physical
22863883
NPL4_HUMANNPLOC4physical
22863883
OGT1_HUMANOGTphysical
22863883
PPME1_HUMANPPME1physical
22863883
2A5D_HUMANPPP2R5Dphysical
22863883
RAGP1_HUMANRANGAP1physical
22863883
RADI_HUMANRDXphysical
22863883
SHLB1_HUMANSH3GLB1physical
22863883
TPRKB_HUMANTPRKBphysical
22863883
UBE3A_HUMANUBE3Aphysical
22863883
ZPR1_HUMANZPR1physical
22863883

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LPP_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375 AND THR-397, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-333, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-300 AND TYR-301, ANDMASS SPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-317, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-301 AND TYR-317, ANDMASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-300; TYR-301 ANDTYR-317, AND MASS SPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-301, AND MASSSPECTROMETRY.
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry.";
Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.;
Anal. Chem. 76:2763-2772(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-297 AND TYR-300, ANDMASS SPECTROMETRY.
"Profiling of tyrosine phosphorylation pathways in human cells usingmass spectrometry.";
Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.;
Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-301, AND MASSSPECTROMETRY.

TOP